Cite
HARVARD Citation
Shkolyar, E. et al. (2018). Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, Pulmonary Hypertension, and Lower Urinary Tract Symptoms. Journal of sexual medicine. 15 (7), pp. 982-989. [Online].